Speaker:

David Lott, MD  Director, Voice Program, Department of Otolaryngology Head & Neck Surgery/Audiology, Mayo Clinic, Phoenix, Arizona. Director, Head & Neck Regeneration Laboratory, Mayo Clinic in Arizona, Phoenix, Arizona. Director, Head & Neck Transplantation Program, Department of Otolaryngology, Head & Neck Surgery/Audiology, May Clinic, Phoenix, Arizona. Associate Professor of Otolaryngology, Mayo Clinic College of Medicine. Consultant, Department of Otolaryngology Head & Neck Surgery/Audiology, Mayo Clinic, Scottsdale, Arizona.

Objectives: 

• Recognize the severe life-threatening and quality of life issues associated with laryngotracheal dysfunction.
• Understand the benefits of the new Mayo Clinic Head and neck Transplantation Program.
• Identify patient care needs for this specialized patient population.

MMI Presentation:

Jeffrey Munro, DO

Locations:    

• Mayo Clinic Building, Taylor Auditorium
• Mayo Clinic Hospital, MCH Waugh Auditorium Side A (MCH 1-220A)
• Mayo Clinic Women’s Health Internal Medicine
• Mayo Clinic Family Medicine – Arrowhead
• Kingman Regional Medical Center
• Yuma Regional Medical Center
• Canyon Ranch Medical Center
• Mayo Clinic Primary Care – San Tan

ALL PHYSICIANS AND ALLIED STAFF ARE WELCOME

**NEW** ATTENDANCE REQUIREMENT 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.

FACULTY DISCLOSURE

As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.